Immune cell functions are currently hidden biomarkers for clinical routine due to logistical issues for in-vitro diagnostics. Point-of-care systems would be able to provide precision measurements of such non-stable biomarkers. Our platform technology has the potential to give clinicians access to immune cell functions without compromising on measurement precision to support clinical decision-making.
Life-Science-Incubator (LSI) funded research project at Bonn, Germany (www.life-science-inkubator.de) at the research center Ceasar:
- Topic: Development of a point-of-care flow cytometer operating in whole blood based on existing lab-prototype systems developed at Siemens (nature.com/articles/srep32838). The technology was transferred to EarlyBio GmbH in 2017.
- Recruit and lead a team of engineers at Bonn, Germany
- Report project results to LSI Bonn and Earlybio management
- Develop a unit-use cartridge and low-cost reader for research-use-only
- Develop a supply chain and quality control system
- Organize due diligences for investors
- Demonstrate measurement precision with clinical samples.
- Lead an effective team and achieve a financial round in 2021 to develop an in-vitro diagnostic product and perform clinical trials
- Lead an engineering team
- Industrial work experience
- Experience in healthcare and QC is favorable
Project lead will have the opportunity for professional management training at LSI to develop skills to run a startup.
Please send your application to email@example.com.